✦ LIBER ✦

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C

✍ Scribed by Karen L. Lindsay; Christian Trepo; Tobias Heintges; Mitchell L. Shiffman; Stuart C. Gordon; John C. Hoefs; Eugene R. Schiff; Zachary D. Goodman; Mark Laughlin; Ruji Yao; Janice K. Albrecht

Book ID: 111721569
Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 149 KB
Volume: 34
Category: Article
ISSN: 0270-9139
DOI: 10.1053/jhep.2001.26371

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, Double-Blind, Placebo-Contro

Randomized, Double-Blind, Placebo-Controlled Trial of Interferon Alfa2a With and Without Amantadine as Initial Treatment for Chronic Hepatitis C

✍ Stefan Zeuzem; Gerlinde Teuber; Uta Naumann; Thomas Berg; Jochen Raedle; Susanne 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB

Interferon Alfa-2b Alone or in Combinati

Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C

✍ McHutchison, John G.; Gordon, Stuart C.; Schiff, Eugene R.; Shiffman, Mitchell L 📂 Article 📅 1998 🏛 Massachusetts Medical Society 🌐 English ⚖ 163 KB

A prospective, randomized trial comparin

A prospective, randomized trial comparing lymphoblastoid to recombinant interferon alfa 2a as therapy for chronic hepatitis C

✍ M Rumi; E Del Ninno; M L Parravicini; R Romeo; R Soffredini; M F Donato; J Wilbe 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 1 views

Randomized trial comparing three differe

Randomized trial comparing three different regimens of interferon alfa 2a in chronic hepatitis C

✍ M Angelico 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

small numbers of HCC cells may be released into the man research review committee. Informed consent had been obtained from the patients involved. circulation, be it spontaneously or induced by surgical The results show that albumin mRNA can be demanipulation. Based on their findings, the authors su

Response to higher doses of interferon a

Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: A randomized multicenter trial

✍ K L Lindsay; G L Davis; E R Schiff; H C Bodenheimer; L A Balart; J L Dienstag; R 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

JANICE ALBRECHT, 12 AND THE HEPATITIS INTERVENTIONAL THERAPY GROUP\* with continued therapy at that dose; however, a propor-To evaluate response rates to 3, 5, or 10 million units tion of patients who do not respond to 12 weeks of treat-(MU) of interferon alfa-2b, given thrice weekly, and to ment wi

Treatment of hepatitis C virus–related c

Treatment of hepatitis C virus–related cirrhosis: A randomized, controlled trial of interferon alfa-2b versus no treatment

✍ Dominique-Charles Valla; Michele Chevallier; Patrick Marcellin; Jean-Louis Payen 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

To examine the effects of interferon (IFN) therapy on clinical, biochemical, and histological features in patients with compensated hepatitis C virus (HCV)-related cirrhosis, we have conducted a randomized, controlled trial of IFN therapy versus observation. Eight centers included a total of 99 pati